CHROMIC CHLORIDE IN PLASTIC CONTAINER
Details
- Status
- Prescription
- First Approved
- 1986-06-26
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
CHROMIC CHLORIDE IN PLASTIC CONTAINER Approval History
What CHROMIC CHLORIDE IN PLASTIC CONTAINER Treats
1 indicationsCHROMIC CHLORIDE IN PLASTIC CONTAINER is approved for 1 conditions since its original approval in 1986. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Chromium Deficiency
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CHROMIC CHLORIDE IN PLASTIC CONTAINER FDA Label Details
ProIndications & Usage
FDA Label (PDF)Chromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.